SCC489
VOA1066 Human Undifferentiated Endometrial Carcinoma Cell Line
Human
別名:
VOA1066;VOA1066 cell line;human endometrial cell line;human endometrial carcinoma cell line;endometrial carcinoma cell line;endometrial cancer cell line;human endometrial cancer cell line
ログイン組織・契約価格を表示する
すべての画像(5)
About This Item
おすすめの製品
製品名
VOA1066 Human Undifferentiated Endometrial Carcinoma Cell Line,
由来生物
human
品質水準
包装
vial of ≥1X10⁶ cells/vial vials
メーカー/製品名
Millipore
テクニック
cell culture | mammalian: suitable
cell differentiation: suitable
輸送温度
liquid nitrogen
保管温度
−196°C
アプリケーション
- Each vial contains >=1X106 viable cells.
- VOA1066 cells are verified to be of human origin and negative for mouse, rat, Chinese hamster, Golden Syrian hamster, and non-human primate interspecies contamination, as assessed by a Contamination Clear panel by Charles River Animal Diagnostic Services
- Cells tested negative for infectious diseases against a Human Essential CLEAR panel by Charles River Animal Diagnostic Services.
- Cells tested negative for mycoplasma.
特徴および利点
The VOA1066 cell line is highly tumorigenic in vivo, with a stable genome demonstrating few somatic mutations. These cells may prove useful for studying the roles of ARID1A and ARID1B in undifferentiated endometrial carcinoma, and for the development of endometrial carcinoma therapeutics.
ターゲットの説明
Endometrial cancer (EC) is the sixth most common cancer globally in women, with an estimated 417,367 new cases in 2020 (1). EC can be divided into two types: estrogen-dependent type I which is the most common, and estrogen-independent type II that is more aggressive (2). Within type II, a subtype is dedifferentiated EC, where an undifferentiated carcinoma develops from a low-grade endometroid endometrial cancer (2). Dedifferentiated EC has a worse prognosis, with a median survival of 6 months and disease-related death rate ranges from 41% to 75% ocurring in the first 5 years after diagnosis (3).VOA1066 is a human undifferentiated endometrial carcinoma cell line derived from endometrial primary tumor tissue collected at the time of surgery from a 74-year old woman (2). VOA1066 is tumorogenic in vivo, has metastatic ability in immunodeficient mice and the xenografted tumor morpholgy is similar to that of the primary tumor. This cell line is chromosome and genome stable, and has a single translocation identified by karyotype (2). VOA1066 contains few somatic mutations which include inactivating mutations of ARID1A and ARID1B, and a heterozygous hotspot DICER1 mutation in its RNase IIIb domain (2). Genomic studies of dedifferentiated EC have shown three types of inactivating mutations in subunits of the SWI/SNF chromatin remodeling complex including SMARCA4, SMARCB1 and ARID1B (4). VOA1066 can be used to study the effects of SWI/SNF mutations in EC as well as to understand the pathogenesis of the disease.Source:VOA1066 undifferentiated endometrial carcinoma cell line was isolated from endometrial primary tumor tissue.References: 1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. 2021. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 71(3): 209–249.2. Wang Y, Tao VL, Shin CY, Salamanca C, Chen SY, Chow C, Köbel M, Ben-Neriah S, Farnell D, Steidl C, et al. 2020. Establishment and characterization of VOA1066 cells: An undifferentiated endometrial carcinoma cell line. PLoS One. 15(10): e0240412. 3. Al-Loh S, Al-Hussaini M. 2013. Undifferentiated endometrial carcinoma: a diagnosis frequently overlooked. Arch Pathol Lab Med. 137(3): 438–442. 4. Wang Y, Hoang L, Ji JX, Huntsman DG. 2020. SWI/SNF complex mutations in gynecologic cancers: molecular mechanisms and models. Annu Rev Pathol. 15: 467–492.
保管および安定性
VOA1066 cells should be stored in liquid nitrogen until use. The cells can be cultured for at least 10 passages after initial thawing without significantly affecting the cell marker expression and functionality.
免責事項
RESEARCH USE ONLY. This product is regulated in France when intended to be used for scientific purposes, including for import and export activities (Article L 1211-1 paragraph 2 of the Public Health Code). The purchaser (i.e. enduser) is required to obtain an import authorization from the France Ministry of Research referred in the Article L1245-5-1 II. of Public Health Code. By ordering this product, you are confirming that you have obtained the proper import authorization.
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
保管分類コード
10 - Combustible liquids
WGK
WGK 3
引火点(°F)
Not applicable
引火点(℃)
Not applicable
適用法令
試験研究用途を考慮した関連法令を主に挙げております。化学物質以外については、一部の情報のみ提供しています。 製品を安全かつ合法的に使用することは、使用者の義務です。最新情報により修正される場合があります。WEBの反映には時間を要することがあるため、適宜SDSをご参照ください。
Jan Code
SCC489:
試験成績書(COA)
製品のロット番号・バッチ番号を入力して、試験成績書(COA) を検索できます。ロット番号・バッチ番号は、製品ラベルに「Lot」または「Batch」に続いて記載されています。
ライフサイエンス、有機合成、材料科学、クロマトグラフィー、分析など、あらゆる分野の研究に経験のあるメンバーがおります。.
製品に関するお問い合わせはこちら(テクニカルサービス)